This will be a two-day meeting for clinical pharmacologists, scientists and pediatricians to discuss overcoming the scientific challenges using tools such as models & simulations and PK & PD studies to optimise the development of new pediatric medicines.

It is well known that recent regulatory changes in the USA and Europe have made it mandatory to further development of medicines for children. Many previous discussions have taken place on the impact these regulatory changes have had or the difficult topics of locating willing pediatric populations and informed consent.

However NextLevel Pharma's focused and interactive event will look to concentrate on the importance and place of pharmacokinetic and pharmacodynamic studies to answer the questions of how children metabolize drugs differently. It will explore the best use of modeling and simulations, what extrapolation is possible from existing data, how to assess optimal drug dosage levels, measure the drugs interactions on child physiology with minimal samples and subjects to optimise the design of studies for pediatric treatments.

Experienced industry pharmacologists and pediatricians will join us to discuss recent developments and assess how to better understand optimum drug formulation and dosage, as well as measure the efficacy and understand the drugs interactions.

Why Attend?
  • Hear fresh perspectives from experienced pharmaceutical companies who have designed successful pk/pd pediatric studies.

  • Learn what place pk/pd studies have in the development of pediatric drugs and how they can be used more effectively to determine dosages, measure efficacy and demonstrate value to the pediatric world.

  • Hear case study presentations from industry leaders on how to adapt methods used from adults to children.

  • Discover what approaches are best to predict dosage, utilize existing (adult) data, and understand the interactions between drug and child.
Who should attend?

Pharmaceutical & Biotechnology Organisations:

Vice- Presidents, Directors, Managers; Pediatrics, Pre-Clinical and Clinical Pharmacologists, Modeling and Simulation Specialists,

CROs & Solution Providers:

CEOs, Business Development Directors, Product Managers, Marketing Managers Academics; Pediatricians, pharmacologists and scientists involved in the development of new pediatric medicines

Agenda request

Utilising advanced methodologies & technology to improve drug development for children

Conference Dates: 13th-14th September, 2010
Venue: Brussels, Belgium

For Booking Information contact:

Erika Vavrovicova
Tel: +421 232 660 382
Fax: +421 233 010 331
erika@nextlevelpharma.com
http://www.nextlevelpharma.com